📈 Stocks
Novo Holdings Opens Obesity Drug Incubators Across Europe to Boost Weight-Loss Pipeline
(48 minutes ago)
Novo Holdings launches Europe-wide obesity drug incubators to strengthen Novo Nordisk's weight-loss R&D and challenge rivals in the booming GLP-1 market.